Latin American Cooperative Oncology Group

This study is testing whether some patients with early-stage, HER2-positive breast cancer can safely avoid chemotherapy before surgery. Researchers are using a special scan and specific tumor markers to identify patients whose cancer is highly dependent on the HER2 protein. These…

This study aimed to see if a standard drug combination for advanced prostate cancer works differently for men of different racial and ethnic backgrounds. It planned to enroll men who identified as Black, Hispanic, White, or Native American. The trial was withdrawn before any part…

This study is testing a new approach called 'extreme bipolar androgen therapy' for men with advanced prostate cancer that has spread and stopped responding to standard hormone treatments. It alternates high doses of testosterone with a drug that blocks testosterone's effects, aim…

This study is testing a combination of three drugs (amivantamab, lazertinib, and pemetrexed) as the first treatment for people with advanced non-small cell lung cancer that has spread and has specific genetic changes (EGFR mutations). The goal is to see if this powerful combinati…